Aristeia Capital’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
Aristeia Capital's EBS Position: Q3 2026 in Review
Aristeia Capital sold out of Emergent Biosolutions (EBS) in Q3 2026, closing a stake of 161,753 shares — an estimated $1.36M sold.
Aristeia Capital first reported a position in EBS in Q1 2024 and held it in 6 quarters. The position peaked at $1.36M in Q2 2026. 183 funds tracked by Wall St. Rank hold EBS as of Q3 2026.
- Aristeia Capital reported no remaining Emergent Biosolutions position as of Q3 2026 after selling out during the quarter.
- Aristeia Capital sold 161,753 Emergent Biosolutions shares in Q3 2026, an estimated $1.36M.
- Aristeia Capital first reported a position in Emergent Biosolutions in Q1 2024 and held it in 6 quarters.
- Aristeia Capital's Emergent Biosolutions position peaked at $1.36M in Q2 2026.
- 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.
Based on Aristeia Capital's 13F filing for Q3 2026, filed 16 Nov 2026.